What is the differential diagnosis for hypokalemic periodic paralysis?

Differential Diagnosis of Hypokalemic Periodic Paralysis

The differential diagnosis of hypokalemic periodic paralysis must distinguish between primary (genetic) channelopathies and secondary causes, with thyrotoxic periodic paralysis being the most critical acquired etiology to identify, as it is completely reversible with treatment of the underlying hyperthyroidism.

Primary (Genetic) Hypokalemic Periodic Paralysis

Familial Hypokalemic Periodic Paralysis

• Autosomal dominant channelopathy caused by mutations in skeletal muscle ion channel genes, specifically CACNA1S (calcium channel) or SCN4A (sodium channel) genes 1, 2
• Typically presents with earlier age of onset (mean 6-35 years) compared to secondary causes, with males affected more commonly than females (3.5:1 ratio) 3, 4
• Characterized by recurrent episodes of flaccid muscle weakness triggered by rest after exercise, high-carbohydrate meals, stress, or cold exposure 1, 5
• Positive family history in approximately 50-60% of cases, though sporadic cases occur 3, 4
• Attacks are self-limited, typically lasting hours to days, with complete recovery between episodes initially 1, 3
• May evolve to persistent proximal myopathy in late adulthood, particularly with CACNA1S mutations 6

Andersen-Tawil Syndrome

• Caused by loss-of-function mutations in KCNJ2 gene (Kir2.1 potassium channel) 1, 7
• Distinguished by the triad of periodic paralysis, cardiac arrhythmias (prolonged QT interval, ventricular ectopy), and dysmorphic features (low-set ears, hypertelorism, small mandible) 8, 1
• Unique among periodic paralyses because weakness can occur with either low or high serum potassium 7
• Cardiac manifestations are the most dangerous feature and require continuous monitoring 8

Secondary Causes of Hypokalemic Periodic Paralysis

Thyrotoxic Periodic Paralysis (Most Important Secondary Cause)

• Most common treatable cause of acquired periodic paralysis and must be included in every differential diagnosis of acute muscle weakness with hypokalemia 9, 10
• Predominantly affects Asian males in their third decade (though can occur in any ethnicity), with male-to-female ratio of approximately 20-30:1 9, 10
• Graves' disease is the most common underlying cause of hyperthyroidism 10
• Clinical signs of hyperthyroidism may be subtle or absent during presentation—weight loss, tachycardia, goiter, tremor, and ophthalmopathy are common but not universal 9
• Attacks typically arise during the night or early morning and may recover spontaneously, but severe cases can progress to total quadriplegia with cardiac arrhythmias 9
• Serum potassium is typically more severely depressed (<2.5 mEq/L) compared to primary periodic paralysis 3
• Thyroid function tests (suppressed TSH, elevated T4/T3) are mandatory in all cases of hypokalemic periodic paralysis to avoid missing this diagnosis 10
• Complete resolution of paralytic attacks occurs with correction of thyroid function; attacks do not recur once euthyroid state is achieved 9, 10

Renal and Gastrointestinal Causes

• Renal tubular acidosis can present with chronic hypokalemia and episodic weakness, distinguished by metabolic acidosis and abnormal urine pH 8
• Gastroenteritis with severe diarrhea or vomiting causes acute potassium depletion and weakness 3
• High-output gastrointestinal losses (fistulas, ileostomy) lead to ongoing potassium wasting 11
• These causes are distinguished by clear history of fluid losses and typically show more gradual onset of weakness 3

Medication-Induced Hypokalemia

• Diuretic therapy (loop diuretics, thiazides) is the most frequent cause of chronic hypokalemia in clinical practice 8, 11
• Beta-agonist therapy (albuterol) causes transcellular potassium shift 11
• Insulin excess drives potassium intracellularly 11
• Distinguished by clear medication history and resolution with drug discontinuation 11

Endocrine Causes Beyond Thyrotoxicosis

• Primary aldosteronism causes hypertension with hypokalemia and metabolic alkalosis 8
• Cushing syndrome from endogenous or exogenous corticosteroids 8, 11
• These are distinguished by persistent hypokalemia rather than episodic attacks and characteristic hormonal profiles 8

Critical Distinguishing Features in the Differential

Clinical Presentation Patterns

• Symmetrical weakness (paraparesis or quadriparesis) is more common in primary periodic paralysis, while asymmetrical weakness has equal distribution between primary and secondary causes 3
• Respiratory and bulbar involvement is rare in hypokalemic periodic paralysis of any cause, helping distinguish from Guillain-Barré syndrome 8, 3
• Deep tendon reflexes are typically diminished or absent during attacks but may be preserved in mild cases 3
• Sensory examination is normal—any objective sensory signs should prompt consideration of alternative diagnoses such as Guillain-Barré syndrome or spinal cord pathology 8, 3

Severity of Hypokalemia

• Primary periodic paralysis: typically moderate hypokalemia (2.5-3.5 mEq/L) 3
• Secondary causes (especially thyrotoxic): typically severe hypokalemia (<2.5 mEq/L) 3, 9
• Quadriparesis correlates with more severe hypokalemia (mean 2.1 mEq/L) compared to paraparesis 3

Age and Gender Patterns

• Familial forms: earlier onset (childhood to young adulthood), male predominance 3, 4
• Thyrotoxic periodic paralysis: third decade, overwhelming male predominance in Asian populations 9, 10
• Secondary causes (renal, GI): any age, no gender predominance 3

Recovery Time

• Quadriparesis: approximately 24 hours recovery time 3
• Paraparesis: approximately 12 hours recovery time 3
• Thyrotoxic cases: may recover spontaneously but can be life-threatening without treatment 9

Essential Diagnostic Workup to Narrow the Differential

Immediate Laboratory Assessment

• Serum potassium during attack (typically <3.5 mEq/L, often <2.5 mEq/L) 3, 9
• Thyroid function tests (TSH, free T4, T3) are mandatory in all cases to exclude thyrotoxic periodic paralysis 10
• Serum magnesium (target >0.6 mmol/L), as hypomagnesemia makes hypokalemia resistant to correction 11
• Electrocardiogram to assess for arrhythmias and characteristic changes (ST depression, T-wave flattening, prominent U waves) 11, 3

Additional Testing to Identify Secondary Causes

• Renal function (creatinine, eGFR) and urinary potassium excretion to assess for renal losses 8
• Arterial blood gas to evaluate for metabolic acidosis (renal tubular acidosis) or alkalosis (diuretic use, vomiting) 8
• Anti-thyroid antibodies if thyrotoxicosis is confirmed, to identify autoimmune etiology 9

Genetic Testing for Primary Forms

• Molecular genetic testing for CACNA1S, SCN4A, and KCNJ2 mutations should be pursued when primary periodic paralysis is suspected 1, 9, 2
• Glucose-insulin provocation test can be positive in familial cases but is rarely performed due to safety concerns 4

Key Pitfalls to Avoid

• Never assume familial periodic paralysis without checking thyroid function—thyrotoxic periodic paralysis closely mimics familial forms but is completely reversible with thyroid treatment 10
• Do not overlook subtle signs of hyperthyroidism—thyroid dysfunction may not be clinically apparent, making laboratory testing essential 10
• Avoid treating with potassium alone in thyrotoxic cases—definitive treatment requires correction of hyperthyroidism with antithyroid drugs 9, 10
• Consider Guillain-Barré syndrome if sensory signs are present, as this is a critical differential requiring different management 8
• Evaluate for Andersen-Tawil syndrome if cardiac arrhythmias or dysmorphic features are present, as cardiac complications can be life-threatening 8, 1